Registering a CAGR of 3.8% over the forecast period of 2022-2027, the global Crude Heparin market is anticipated to reach the market value of US$ 10825 million in the year 2027 from US$ 3585.4 million in the year 2021.
Crude Heparin Market Overview
Heparin, also known as unfractionated heparin (UFH), is a glycosaminoglycan that arises naturally. It is used as an anticoagulant in medicine (blood thinner). It is mainly useful for the treatment of heart attacks and unstable angina. It is injected into a vein or injected under the skin. It is used to treat a variety of health problems, such as acute coronary syndrome, deep vein thrombosis, pulmonary embolism, and atrial fibrillation, as well as cardiopulmonary bypass and hemofiltration during cardiac surgery. Its use also extends to the administration of major orthopedic procedures such as hip and knee replacements.Heparin is considered as one of the greatest critical life-saving drugs available in the world currently. It can be used for the management and treatment of many chronic diseases.Heparin is a widely used, strongly charged polysaccharide anticoagulant agent. It is used as a drug and incorporated in device.Crude heparin is gained primarily from bovine and porcine sources. Moreover, it has been obtained from other animal and human sources in the past few years. Crude heparin brings some natural impurities, which are purified and processed for pharmaceutical and commercial use purpose.Crude heparin is the base material intended for processing for heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. This is approved for final formulation by US FDA & other regulatory bodies and it is an upstream raw material for heparin.The three main steps in the heparin manufacturing process are: extraction from animal intestines, separation of polysaccharide material, and purification with different acid and base wash
Industry News
In December 2020, Valeo Pharma Inc. received approval from Health Canada for its product 'Redesca and Redesca HP', which is a low molecular weight heparin.
In May 2020, the University of Manitoba initiated a clinical trial to evaluate if heparin, the blood-thinning drug, can be used in the treatment of COVID-19 patients. The clinical trial was conducted at 35 sites, including Canada, the United States, Mexico, and Brazil.
What are the major Applications, Types and Regions for Crude Heparin Market?
By Type, it is segmented into
- Pig Intestine Mucosa Heparin
- Bovine Heparin and Others
Pig intestine mucosa heparin is almost the only used and efficient type, taking 99.47% market share in 2022, in terms of volume.
By Applications it is segmented into
- Unfractionated Heparin (UFH)
- Low-Molecular-Weight Heparin (LMWH)
LMWH is the largest consumer group, with market share of 89.03% in 2022, in terms of volume.
Crude Heparin Market Regional Analysis
North America subject the global crude heparin market in 2022 due to higher demand for heparin for cardiovascular diseases & sports injuries, sophisticated health care infrastructure, presence of large base of animals for raw material of crude heparin, and availability of better quality crude heparin due to regulatory control.
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
The Crude Heparin Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Crude Heparin Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Crude Heparin Market report scope?
Report Attributes
|
Report Details
|
Forecast Period 2022 to 2027 CAGR
|
CAGR of 3.8% during the review period (2022 to 2027).
|
By Type
|
- Pig Intestine Mucosa Heparin
- Bovine Heparin and Others
- Others
|
By Application
|
- Unfractionated Heparin (UFH)
- Low-Molecular-Weight Heparin (LMWH)
- Others
|
By Companies
|
Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong, Hepac (Darling Ingredients), Huaian MDC Pharmaceutical, Yantai Dongcheng Biochemicals.
|
Regions Covered
|
- North America
- Europe
- Asia-Pacific
- Rest of the World
|
Countries Covered
|
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
|
Base Year
|
2022
|
Historical Year
|
2017 to 2021
|
Forecast Year
|
2022 to 2027
|
Number of Pages
|
163
|
Customization Available
|
Yes, the report can be customized as per your needs
|
Key Takeaways from this Crude Heparin Report
- Evaluate Crude Heparin market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.
- Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.
- Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.
- Analyze the sales and distribution channels across geographies to enhance top-line revenues.
- Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.
- Get a quick outlook on the Crude Heparin market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.
- Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.
FAQ -
What is the study period of this market?
The Crude Heparin Drugs Market is studied from 2017 - 2027.
What is the growth rate of Crude Heparin Drugs Market?
The Crude Heparin Drugs Market is growing at a CAGR of 3.8% over the next 5 years.
What regions does this Crude Heparin Drugs Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
